Iridia is a nanotechnology company that specializes in bio-chemistry, molecular biology, and DNA.
Iridia has raised $6.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Iridia's investors include Prime Movers Lab, LifeSci Venture Partners, Longley Capital, TCA Venture Group, ATEM Capital Fund LP.
Iridia is headquartered in Carlsbad, United States.
Iridia is a nanotechnology company that specializes in bio-chemistry, molecular biology, and DNA.
Iridia is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Iridia — Funding & Investors." VCBacked, November 15, 2021, https://www.vcbacked.co/company/iridia. Accessed August 14, 2026.
VCBacked. (2021). Iridia — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/iridia
{{cite web |title=Iridia — Funding & Investors |url=https://www.vcbacked.co/company/iridia |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated